Picture of Altamira Therapeutics logo

CYTOF — Altamira Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Auris Medical Announces Notice Of Allowance For European Patent Application

Jan 10 (Reuters) - Auris Medical Holding Ltd  EARS.O :
    * AURIS MEDICAL ANNOUNCES NOTICE OF ALLOWANCE FOR EUROPEAN
PATENT
APPLICATION
    * AURIS MEDICAL HOLDING - EUROPEAN PATENT OFFICE HAS ISSUED
A
NOTICE OF "INTENTION TO GRANT" FOR ITS PATENT APPLICATION
    * AURIS MEDICAL HOLDING - INTEND TO DEVELOP PROPRIETARY
NKCC1
INHIBITOR THROUGH CO'S NEW SUBSIDIARY, ZILENTIN LTD
    * AURIS MEDICAL HOLDING - CORRESPONDING PATENT APPLICATION
IS
CURRENTLY PENDING BEFORE U.S. PATENT & TRADEMARK OFFICE AND WAS
ALREADY GRANTED IN JAPAN

Source text for Eikon:  ID:nGNX7LDMwy 
Further company coverage:  EARS.O 

 ((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))

Recent news on Altamira Therapeutics

See all news